Full Text View
Tabular View
No Study Results Posted
Related Studies
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
This study is ongoing, but not recruiting participants.
First Received: March 13, 2008   Last Updated: May 11, 2009   History of Changes
Sponsor: Cougar Biotechnology, Inc.
Information provided by: Cougar Biotechnology, Inc.
ClinicalTrials.gov Identifier: NCT00638690
  Purpose

This is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer (CRPC) who have failed one or two chemotherapy regimens. At least one of the previous chemotherapies must have contained docetaxel


Condition Intervention Phase
Metastatic Castration-Resistant Prostate Cancer
Drug: placebo plus prednisone/prednisolone
Drug: abiraterone acetate plus prednisone/prednisolone
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

Resource links provided by NLM:


Further study details as provided by Cougar Biotechnology, Inc.:

Primary Outcome Measures:
  • Overall Survival [ Time Frame: During the Study ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Proportion of patients achieving a PSA decline ≥ 50% according to Prostate Specific Antigen Working Group (PSAWG) criteria [ Time Frame: During Study Treatment ] [ Designated as safety issue: No ]

Estimated Enrollment: 1158
Study Start Date: April 2008
Estimated Study Completion Date: June 2011
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
abiraterone acetate plus prednisone/prednisolone
Drug: abiraterone acetate plus prednisone/prednisolone
1000mg Daily/5mg Twice Daily
2: Placebo Comparator
placebo plus prednisone/prednisolone
Drug: placebo plus prednisone/prednisolone
1000mg Daily/5mg Twice Daily

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Major Inclusion Criteria:

  • Metastatic Castration-Resistant Prostate Cancer
  • Progression after one or two prior cytotoxic chemotherapies. At least one chemotherapy must have contained docetaxel
  • ECOG Performance Status less than/ equal to 2
  • Medical or surgical castration with testosterone less than 50 ng/dL
  • Adequate bone marrow, hepatic and renal function
  • Potassium greater than/ equal to 3.5 mmol/L
  • Able to swallow the study drug whole as a tablet
  • Informed Consent

Major Exclusion Criteria:

  • More than two prior cytotoxic chemotherapy regimens
  • Prior Ketoconazole for prostate cancer
  • Prior Abiraterone acetate or other CYP17 inhibitor or investigational agents targeting the androgen receptor for prostate cancer
  • Uncontrolled hypertension
  • Active or symptomatic viral hepatitis or chronic liver disease
  • History of pituitary or adrenal dysfunction
  • Clinically significant heart disease
  • Other malignancy
  • Known brain metastasis
  • GI disorder affecting absorption
  • Not willing to use contraception
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00638690

  Hide Study Locations
Locations
United States, Alabama
Birmingham Hematology and Oncology Associates, LLC, Bruno Cancer Center
Birmingham, Alabama, United States, 35205
United States, Arizona
Arizona Clinical Research Center, Inc.
Tuscon, Arizona, United States, 85715
United States, California
Prostate Oncology Specialists, Inc.
Marina Del Rey, California, United States, 90292
The Angeles Clinic and Research Institute
Los Angeles, California, United States, 90025
University of California, Los Angeles School of Medicine
Los Angeles, California, United States, 90095
Pacific Hemotology/Oncology
San Francisco, California, United States, 94115
Sharp Clinical Oncology Research
San Diego, California, United States, 92123
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States, 94115
Tower Cancer Research Foundation
Beverly Hills, California, United States, 90211
City of Hope
Duarte, California, United States, 91010
UC Davis Cancer Center
Salto, California, United States, 95817
United States, Colorado
University of Colorado Cancer Center
Aurora, Colorado, United States, 80045
United States, Connecticut
The Hope Clinic
Bristol, Connecticut, United States, 06010
Hematology Oncology, P.C. Carl and Dorothy Bennett Cancer Center
Stamford, Connecticut, United States, 06902
Yale Medical Group
New Haven, Connecticut, United States, 06520
United States, Florida
Florida Cancer Specialists
Fort Myers, Florida, United States, 33901
The Center for Hematology-Oncology
Boca Raton, Florida, United States, 33486
Bienes Cancer Center
Fort Lauderdale, Florida, United States, 33308
Palm Beach Cancer Institute
West Palm Beach, Florida, United States, 33403
United States, Georgia
Peachtree Hematology & Oncology
Atlanta, Georgia, United States, 30309
Georgia Cancer Specialists
Tucker, Georgia, United States, 30084
United States, Hawaii
Kaiser Permanente Medical Group
Honolulu, Hawaii, United States, 96819
United States, Illinois
Medical and surgical specialists
Galesburg, Illinois, United States, 61401
Rush University Medical Center
Chicago, Illinois, United States, 60612
United States, Indiana
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States, 46202
United States, Kansas
Cancer Center of Kansas, P.A.
Wichita, Kansas, United States, 67214
University of Kansas Medical Center
Westwood, Kansas, United States, 66205
United States, Louisiana
Hematology and Oncology Specialists
Metairie, Louisiana, United States, 70006
Tulane University School of Medicine (Medical Oncologist)
New Orleans, Louisiana, United States, 70112
United States, Maryland
The Sidney Kimmel Comprehensive Cancer at John Hopkins
Baltimore, Maryland, United States, 21231
United States, Massachusetts
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, Michigan
Henry Ford Health System
Detroit, Michigan, United States, 48202
United States, Minnesota
Hubert Humphrey Cancer Center North Memorial Health Care
Robbinsdale, Minnesota, United States, 55422
United States, Missouri
Washington University St. Louis School Medicine Siteman Cancer Center
St. Louis, Missouri, United States, 63110
United States, Montana
Billings Clinic
Billings, Montana, United States, 59101
United States, Nebraska
Alegent Health Bergan Mercy Hospital
Omaha, Nebraska, United States, 68124
United States, Nevada
Nevada Cancer Institute
Las Vegas, Nevada, United States, 89135
Comprehensive Cancer Center of Nevada
Las Vegas, Nevada, United States, 89169
United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
The Arthur Smith Institute for Urology
New Hyde Park, New York, United States, 11040
North Shore Hematology Oncology Associates
East Setauket, New York, United States, 11733
New York University Medical Center - Weill Cornell Medical College
New York, New York, United States, 10065
SUNY Stony brook
Stony Brook, New York, United States, 11794
NYU Clinical Cancer Center
New York, New York, United States, 10016
United States, North Carolina
Cancer Center of North Carolina
Raleigh, North Carolina, United States, 27607
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157
Duke University Hospital Medical Center
Durham, North Carolina, United States, 27705
United States, Ohio
Gabrail Cancer Center
Canton, Ohio, United States, 44718
Oncology Hematology Care
Cincinnati, Ohio, United States, 45242
United States, Oregon
The Oregon Clinic
Portland, Oregon, United States, 97213
United States, Pennsylvania
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15232
United States, South Carolina
Carolina Urologic Research Center (Urologist)
Myrtle Beach, South Carolina, United States, 29572
United States, Tennessee
Sarah Cannon Research Institute, LLC
Nashville, Tennessee, United States, 37203
Chattanooga Oncology Hematology Associates
Chattanooga, Tennessee, United States, 37404
United States, Texas
University of Texas MD Anderson
Houston, Texas, United States, 77030
Texas Oncology - Sammons Cancer Center
Dallas, Texas, United States, 75246
University of Texas Health Science Center
San Antonio, Texas, United States, 78229
United States, Virginia
Virginia Cancer Institute
Richmond, Virginia, United States, 23230
Urology of Virginia
Norfolk, Virginia, United States, 23502
United States, Washington
University of Washington School of Medicine (Medical Oncologist)
Seattle, Washington, United States, 98109
VA Puget Sound Health Care
Seattle, Washington, United States, 98108
Australia
Ashford Cancer Centre
Ashford, Australia, 5035
Southern Medical Day Care Center
Wollongong, Australia, 2500
Royal Adelaide
Adelaide, Australia, 5000
Royal Melbourne Hospital
Melbourne, Australia, 3050 AU
Royal Hobart Hospital
Hobart, Australia, 7000
Austin Hospital Studley Road
Heidelburg, Australia, 3084
Sydney Haematology Oncology Clinic
Hornsby, Australia, NSW 2077
Haematology and Oncology Clinics of Australasia
South Brisbane, Australia, 4101
Royal Brisbane and Women's Hospital
Herston, Australia, 4029
Border Medical Oncology
Wodonga, Australia, 3690
Western Hospital, Footscray Victoria
Footscray, Australia, 3011
The Mount Hospital
Perth, Australia, 6000
Royal Prince Alfred Hospital
Camperdown, Australia, 2050
Liverpool Hospital
Liverpool, Australia, 2170
St John of God Hospital Subiaco
Subiaco, Australia, 6008
Barwon Health, Geelong Hospital
Victoria, Australia
Australia, New South Wales
St. George Private Hospital, Oncology Day Care Centre
Kogarah, New South Wales, Australia, 2217
Austria
Department of Urology Medical University of Vienna
Vienna, Austria, A-1090
Universitätsklinik für Urologie und Andrologie, Allgemeines Krankenhaus Salzburg
Salzburg, Austria, A-5020 AT
Urologische Abteilung Krankenhaus der Barmherzigen Schwestern Linz
Linz, Austria, 4020
Belgium
UZ Gasthuisberg
Leuven, Belgium, B-3000
UZ Gent
Gent, Belgium, B-9000
Catholic University Hospital St. Luc
Bruxelles, Belgium, 1200
Middelheim ziekenhuis
Antwerp, Belgium, 2020
Virga Jesseziekenhuis
Hasselt, Belgium, B-3500
Imelda zieknhuis
Bonheiden, Belgium, 2820
H.Hart ziekenhuis
Roeselare, Belgium, B-8800
CHU Sart-Tilman
Liege, Belgium, 4000
Urologie AZ Groeninge
Kortrijk, Belgium, B-8500
AZ Sint Lucas
Gent, Belgium, 9000
Canada
Tom Baker Cancer Centre
Calgary, Canada, T2N 4N2
Cross Cancer Institute
Alberta, Canada
Canada, British Columbia
British Columbia Cancer Agency - Vancouver Clinic
Vancouver, British Columbia, Canada, V5Z 4E6
British Columbia Cancer Agency-Centre for the Southern Interior
Kelowna, British Columbia, Canada, V1Y 5L3
British Columbia Cancer Agency - Vancouver Island Cancer Centre
Victoria, British Columbia, Canada, V8R 6V5
Canada, Nova Scotia
Nova Scotia, Centre for Clinical Research Cancer Care Program
Halifax, Nova Scotia, Canada, B3H1V7
Canada, Ontario
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Juravinski Cancer Centre Hamilton Health Services
Hamilton, Ontario, Canada, L8V 5C2
London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada, N6A 4L6
Canada, Quebec
Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame
Montreal, Quebec, Canada, H2L 4M1
McGill Department of Oncology, Clinical Research Program
Montreal, Quebec, Canada, H2W 1S6
Canada, Saskatchewan
Allan Blair Cancer Center at Pasqua Hospital
Regina, Saskatchewan, Canada, S4T7T1
France
Institut Gustave-Roussy
France, France, 94805
Centre Hosptialier de Cannes
Cannes, France, 06401
Centre René Gauducheau
Nantes-St Herblain, France, F-44805
Centre Alexis Vautrin
Vandoeuvre Les Nancy Cedex, France, 54511
Centre Georges François Leclerc
Dijon, France, 21079
Centre François Baclesse
Caen cedex 5, France, 14076
Centre Léon Bérard
Lyon 08, France, 69373
Centre Paul Papin
Angers Cedex 9, France, 49933
Germany
Universitätsklinikum des Saarlandes
Homburg/Saar, Germany, 66421
Urologische Gemeinschaftspraxis
Hamburg, Germany, 22355
Charite Campus Benjamin Franklin
Berlin, Germany, 12203
Universitatsklinikum "Carl Gustav Carus" der Technischen
Dresden, Germany, 01307
Universitatsklinikum Aachen Urologie
Aachen, Germany, 52074
Hungary
County Hospital of Pecs
Pecs, Hungary, 7623 HU
Cholnoky Ferenc County Hospital, Oncology Department
Veszprém, Hungary, H-8200
Markusovszky Lajos Teaching Hospital, Szombathely, Oncoradiology Department
Vas County, Hungary, 9270
Ireland
AMNCH
Dublin, Ireland, 24
Bon Secours Hospital
Cork, Ireland, 00000
Oncology Trials Unit CUH/MUH/SIVUH
Cork, Ireland, 0000
Mater Private Hospital
Dublin, Ireland, 7
Beaumont Hospital
Dublin, Ireland, 9
Italy
Az. Ospedaliera San Camillo-Forlanini
Roma, Italy, 00152
Hospital "Misericordia" USL
Via Senese 161, Italy, 58100
Arcispedale Santa Maria Nuova
Reggio Emilia, Italy, 42100
Policlinico de Modena
Modena, Italy, 41100
Hospital San Raffaele
Milan, Italy, 20132
Netherlands
U.M.C. St. Radboud, Nijmegen
Nijmegen, Netherlands, 6500 GA
Spain
Hospital del Mar
Barcelona, Spain, 08003
Hospital Germans Trias i Pujol
Badalona, Spain, 08916
Hospital Son Dureta
Palma de Mallorca, Spain, 07014
Hospital Madrid Norte Sanchinarro
Madrid, Spain, 28050
Hospital Clinic i Provincial
Barcelona, Spain, 08036
Clínica Universitaria de Navarra
Pamplona, Spain, 31008
Institut Català d'Oncologia
Barcelona, Spain, 08907
United Kingdom
Royal Marsden Hospital
Sutton, United Kingdom
Hammersmith Hospital
London, United Kingdom, W12 0NN
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom, G12 0YN
Freeman Hospital
Newcastle upon Tyne, United Kingdom, NE7 7DN
The Christie Hosptial
Manchester, United Kingdom, M20 4BX
Addenbrooke's Hospital
Cambridge, United Kingdom, CB2 0QQ
Velindre Hospital, Wales College of Medicine
Cardiff, United Kingdom, CF14-2TL
University College London Hospitals
London, United Kingdom, NW1 2PG
Mount Vernon Cancer Centre
Northwood, United Kingdom, HA6 2RN
Northern Ireland Cancer Centre, Belfast City Hosp.
Lisburn Road, United Kingdom, BT9 7AB
United Kingdom, Birmingham
CR-UK Institute for Cancer Studies, University of Birmingham
Edgbaston, Birmingham, United Kingdom, B15 2TT
United Kingdom, Oxford
Oxford Cancer Centre
Old Road Headington, Oxford, United Kingdom, OX3 7LT
Sponsors and Collaborators
Cougar Biotechnology, Inc.
Investigators
Study Chair: Howard I Scher, MD Memorial Sloan-Kettering Cancer Center
Study Chair: JS de Bono, MD FRCP PhD ICR/Royal Marsden Hospital
  More Information

Additional Information:
No publications provided

Responsible Party: Cougar Biotechnology, Inc. ( Christopher M. Haqq MD PhD )
Study ID Numbers: COU-AA-301
Study First Received: March 13, 2008
Last Updated: May 11, 2009
ClinicalTrials.gov Identifier: NCT00638690     History of Changes
Health Authority: United States: Food and Drug Administration;   European Union: European Medicines Agency;   Australia: National Health and Medical Research Council;   Canada: Health Canada

Keywords provided by Cougar Biotechnology, Inc.:
Metastatic Castration Resistant Prostate Cancer
CRPC
Abiraterone Acetate
CB7630

Additional relevant MeSH terms:
Prednisolone acetate
Methylprednisolone acetate
Anti-Inflammatory Agents
Prednisone
Prostatic Diseases
Genital Neoplasms, Male
Methylprednisolone
Antineoplastic Agents
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Antiemetics
Urogenital Neoplasms
Neuroprotective Agents
Hormones
Neoplasms by Site
Therapeutic Uses
Methylprednisolone Hemisuccinate
Antineoplastic Agents, Hormonal
Gastrointestinal Agents
Genital Diseases, Male
Protective Agents
Glucocorticoids
Pharmacologic Actions
Neoplasms
Autonomic Agents
Prednisolone
Peripheral Nervous System Agents
Central Nervous System Agents
Prostatic Neoplasms

ClinicalTrials.gov processed this record on February 08, 2010